The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company’s web site at www.femalehealth.com.
- 16 years ago
QualityStocks
The Female Health Company (AMEX: FHC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – AirJoule Technologies Corporation (NASDAQ: AIRJ) Secures $15 Million Private Placement Led by GE Vernova
AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million…
-
QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering
BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering…
-
Nightfood Holdings Inc. (NGTF) Accelerates Growth Through Strategic Acquisitions in AI-Driven Hospitality, Hotel Management
Report notes that the increasing pace of transactions serves as an encouraging sign for the…